About Inspire Medical Systems (INSP)

Inspire Medical Systems Inc (INSP) is a medical technology company that specializes in the development and commercialization of innovative solutions for obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy system, is a unique and minimally invasive implantable device that provides a safe and effective treatment option for patients with OSA who are unable or unwilling to use continuous positive airway pressure (CPAP) therapy. By delivering mild stimulation to the hypoglossal nerve during sleep, the device helps maintain an open airway and prevent apnea events.

INSP's stock price history reflects the growing popularity and success of its Inspire therapy system. Since its initial public offering (IPO) in May 2018, the stock has experienced steady growth, with occasional fluctuations due to market conditions and company announcements. Investors have been attracted to INSP's strong financial performance, as the company has consistently reported impressive revenue growth and positive earnings. The stock's performance has also been bolstered by the increasing recognition of obstructive sleep apnea as a widespread and significant health issue, as well as the growing demand for alternative treatment options to CPAP therapy.